Your browser doesn't support javascript.
loading
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Metzger, Todd C; Long, Hua; Potluri, Shobha; Pertel, Thomas; Bailey-Bucktrout, Samantha L; Lin, John C; Fu, Tihui; Sharma, Padmanee; Allison, James P; Feldman, Reid M R.
Afiliación
  • Metzger TC; Rinat Laboratories, Pfizer Inc., South San Francisco, California. Todd.Metzger@pfizer.com Reid.Feldman@pfizer.com.
  • Long H; Rinat Laboratories, Pfizer Inc., South San Francisco, California.
  • Potluri S; Rinat Laboratories, Pfizer Inc., South San Francisco, California.
  • Pertel T; Rinat Laboratories, Pfizer Inc., South San Francisco, California.
  • Bailey-Bucktrout SL; Rinat Laboratories, Pfizer Inc., South San Francisco, California.
  • Lin JC; Rinat Laboratories, Pfizer Inc., South San Francisco, California.
  • Fu T; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sharma P; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Allison JP; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Feldman RM; Rinat Laboratories, Pfizer Inc., South San Francisco, California. Todd.Metzger@pfizer.com Reid.Feldman@pfizer.com.
Cancer Res ; 76(13): 3684-9, 2016 07 01.
Article en En | MEDLINE | ID: mdl-27197182
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Linfocitos T Reguladores / Linfocitos T CD8-positivos / Receptores OX40 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Linfocitos T Reguladores / Linfocitos T CD8-positivos / Receptores OX40 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article